JP2020078318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020078318A5 JP2020078318A5 JP2020015937A JP2020015937A JP2020078318A5 JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5 JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020015937 A JP2020015937 A JP 2020015937A JP 2020078318 A5 JP2020078318 A5 JP 2020078318A5
- Authority
- JP
- Japan
- Prior art keywords
- isfahan
- virus
- antigen
- protein
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022095401A JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461946734P | 2014-03-01 | 2014-03-01 | |
| US61/946,734 | 2014-03-01 | ||
| JP2016555578A JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Division JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022095401A Division JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020078318A JP2020078318A (ja) | 2020-05-28 |
| JP2020078318A5 true JP2020078318A5 (https=) | 2021-03-18 |
| JP7454393B2 JP7454393B2 (ja) | 2024-03-22 |
Family
ID=54055975
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Pending JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
| JP2020015937A Active JP7454393B2 (ja) | 2014-03-01 | 2020-02-03 | 組換えイスファハンウイルスベクター |
| JP2022095401A Pending JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555578A Pending JP2017508465A (ja) | 2014-03-01 | 2015-02-27 | 組換えイスファハンウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022095401A Pending JP2022126723A (ja) | 2014-03-01 | 2022-06-14 | 組換えイスファハンウイルスベクター |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9932564B2 (https=) |
| EP (1) | EP3113795B1 (https=) |
| JP (3) | JP2017508465A (https=) |
| KR (1) | KR102416194B1 (https=) |
| CN (1) | CN106794240A (https=) |
| AU (1) | AU2015225553B2 (https=) |
| CA (1) | CA2941261A1 (https=) |
| DK (1) | DK3113795T3 (https=) |
| ES (1) | ES2749381T3 (https=) |
| IL (2) | IL247545B (https=) |
| MX (1) | MX369776B (https=) |
| SG (1) | SG11201607287XA (https=) |
| WO (1) | WO2015134332A2 (https=) |
| ZA (1) | ZA201606036B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
| WO2017070624A1 (en) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Tropical disease vaccines |
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| EP3675817A1 (en) | 2017-08-31 | 2020-07-08 | Modernatx, Inc. | Methods of making lipid nanoparticles |
| WO2019055807A1 (en) | 2017-09-14 | 2019-03-21 | Modernatx, Inc. | RNA VACCINES AGAINST ZIKA VIRUS |
| CN111344008A (zh) * | 2017-09-15 | 2020-06-26 | 俄亥俄州创新基金会 | 用于预防呼吸道合胞病毒(rsv)感染的疫苗及其制备和使用方法 |
| WO2020018705A1 (en) | 2018-07-17 | 2020-01-23 | Yale University | Methods for treatment of cancer using chikungunya-vsv chimeric virus |
| WO2020061457A1 (en) | 2018-09-20 | 2020-03-26 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
| CN115612674B (zh) * | 2021-07-14 | 2026-01-30 | 上海荣瑞医药科技有限公司 | 一种溶瘤病毒及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7153510B1 (en) * | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| CN1764474B (zh) * | 2003-03-26 | 2011-02-02 | 惠氏公司 | 免疫原性组合物及方法 |
| KR101255016B1 (ko) * | 2004-04-09 | 2013-04-17 | 와이어쓰 엘엘씨 | 소포성 구내염 바이러스의 상승적 감쇠, 그의 벡터 및 그의 면역원성 조성물 |
| CA2799469C (en) * | 2004-04-09 | 2016-06-07 | Wyeth | Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| WO2009016433A2 (en) * | 2006-09-15 | 2009-02-05 | Ottawa Health Research Institute | Oncolytic rhabdovirus |
| DK2185192T3 (en) * | 2007-08-03 | 2019-02-18 | Pasteur Institut | LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES |
| JP5779352B2 (ja) * | 2008-03-14 | 2015-09-16 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 複製欠損フラビウイルスワクチンおよびワクチンベクター |
| US9707285B2 (en) * | 2009-03-16 | 2017-07-18 | Turnstone Limited Partnership | Vaccination methods |
| JP5675789B2 (ja) * | 2009-06-08 | 2015-02-25 | ザ ユニバーシティー オブ ウェスタン オンタリオＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｗｅｓｔｅｒｎ Ｏｎｔａｒｉｏ | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 |
| TR201802741T4 (tr) * | 2010-05-14 | 2018-03-21 | Univ Oregon Health & Science | Rekombinant hcmv ve rhcmv vektörleri ve bunların kullanımları. |
| US20130095556A1 (en) * | 2011-09-21 | 2013-04-18 | International Aids Vaccine Initiative | Novel vesicular stomatitis virus and virus rescue system |
-
2015
- 2015-02-27 EP EP15758863.3A patent/EP3113795B1/en active Active
- 2015-02-27 KR KR1020167027395A patent/KR102416194B1/ko not_active Expired - Fee Related
- 2015-02-27 CN CN201580026511.3A patent/CN106794240A/zh active Pending
- 2015-02-27 WO PCT/US2015/018156 patent/WO2015134332A2/en not_active Ceased
- 2015-02-27 JP JP2016555578A patent/JP2017508465A/ja active Pending
- 2015-02-27 AU AU2015225553A patent/AU2015225553B2/en not_active Ceased
- 2015-02-27 ES ES15758863T patent/ES2749381T3/es active Active
- 2015-02-27 DK DK15758863.3T patent/DK3113795T3/da active
- 2015-02-27 CA CA2941261A patent/CA2941261A1/en active Pending
- 2015-02-27 MX MX2016011300A patent/MX369776B/es active IP Right Grant
- 2015-02-27 SG SG11201607287XA patent/SG11201607287XA/en unknown
- 2015-02-27 US US15/122,695 patent/US9932564B2/en active Active
-
2016
- 2016-08-30 IL IL247545A patent/IL247545B/en unknown
- 2016-08-31 ZA ZA2016/06036A patent/ZA201606036B/en unknown
-
2020
- 2020-02-03 JP JP2020015937A patent/JP7454393B2/ja active Active
-
2022
- 2022-01-31 IL IL290258A patent/IL290258A/en unknown
- 2022-06-14 JP JP2022095401A patent/JP2022126723A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020078318A5 (https=) | ||
| US10646557B2 (en) | Vaccine composition | |
| CN103772508B (zh) | 免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗 | |
| Cohen et al. | Modulating the immune response to genetic immunization | |
| Chattergoon et al. | Genetic immunization: a new era in vaccines and immune therapeutics | |
| Ertl et al. | Novel vaccine approaches | |
| WO2021189571A1 (zh) | 一种高效诱导机体体液免疫应答的疫苗载体、其制备方法及用途 | |
| JP2019526580A5 (https=) | ||
| EP3484508A1 (en) | Compositions and methods for alphavirus vaccination | |
| JP2010500399A5 (https=) | ||
| JP2008508866A5 (https=) | ||
| JP2006523224A (ja) | 免疫原性組成物および方法 | |
| WO2003031602A1 (en) | The oncolytic microorganisms expressing hsp and uses thereof | |
| EP2794637A1 (en) | Vesicular stomatitis virus for prime boost vaccines | |
| CA2419822A1 (en) | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization | |
| Ansardi et al. | Characterization of poliovirus replicons encoding carcinoembryonic antigen | |
| JP2025094154A5 (https=) | ||
| JP2021506300A (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）に対する免疫応答を誘導するための方法および組成物 | |
| Gupta et al. | Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag | |
| US11160857B2 (en) | Multivalent enterovirus vaccine compositions and uses related thereto | |
| CN105198982B (zh) | 基于il-6的抗原表位及其应用 | |
| CN115969965A (zh) | 一种结核分枝杆菌的重组dna疫苗及其制备方法 | |
| CN115850520A (zh) | 新型结核病亚单位疫苗al的制备方法和应用 | |
| Xie et al. | Co-administration of antigen with chemokine MCP-3 or MDC/CCL22 enhances DNA vaccine potency | |
| CN101394868A (zh) | 重组腺病毒5型/35型和痘病毒mva活病毒载体疫苗的联用诱导强大的免疫应答的方法 |